Business

Voyageur Pharmaceuticals Ltd., Announces The Creation of a New Scientific Advisory Board With World Class Leading Physicians

(TheNewswire) Calgary, Alberta - TheNewswire - September 14, 2021 - ...

articleVoyageur Pharmaceuticals LtdSeptember 14, 20215/company/voyageur-pharmaceuticals-ltd/news/voyageur-pharmaceuticals-ltd-announces-the-creation-of-a-new-scientific-advisory-board-with-world-class-leading-physicians
Voyageur Pharmaceuticals Ltd., Announces The Creation of a New Scientific Advisory Board With World Class Leading Physicians

About this update from Voyageur Pharmaceuticals Ltd

[{"type":"text","content":"Voyageur Pharmaceuticals Ltd., Announces The Creation of a New Scientific Advisory Board With World Class Leading Physicians \n \n \n (TheNewswire)\n \n \n \n \n \n \n \n \n Calgary, Alberta -\n \n \n TheNewswire\n-\n \n \n September 14, 2021 -\n \n \n Voyageur Pharmaceuticals Ltd.\n(TSXV:VM)\n \n \n (\n \n \n OTC:\n \n \n VYYRF) (the \"Company\" or\n\"Voyageur\") develops, manufactures and will commercialize\nhigh-performance cost effective imaging contrast agents for the\nmedical radiology marketplace. Today the Company announced the\nformation of its Scientific Advisory Board (SAB) to support the\nfirm’s research, clinical and product development programs. The SAB\nis to provide our management team, BOD and our imaging consultants\nDash International with expert advice and counsel that fulfills our\nmission and our vision to provide products that will benefit the\nhealthcare system worldwide. In addition, the SAB will assist with\noutreach to the medical and scientific community, guide and oversee\nVoyageur’s innovative programs and bring strategic perspectives to\nrapidly emerging science and technology trends impacting\nVoyageur.\n \n \n \n \n The SAB comes together with the following leading\nimaging physicians and researchers:\n \n \n \n \n Alec J. Megibow, MD\n \n \n \n \n \n \n - Professor, Department of Radiology, NYU Grossman\nSchool of Medicine\n \n \n \n \n - Professor, Department of Surgery, NYU Grossman School\nof Medicine\n \n \n \n \n - Director, FPO Outpatient Imaging Services, NYU\nLangone Health\n \n \n \n \n - Interests: CT and MRI, liver, pancreas, and\nalimentary tract\n \n \n \n \n \n \n C. Daniel Johnson, MD\n \n \n \n \n \n \n - Professor of Radiology, Mayo College of Medicine and\nScience\n \n \n \n \n - Consultant, Department of Radiology, Mayo Clinic,\nScottsdale AZ.\n \n \n \n \n - Consultant, Department of Radiology, Mayo Clinic,\nRochester, MN\n \n \n \n \n - Adjunct Faculty, College of Health Solutions, Arizona\nState University.\n \n \n \n \n - Interests: Full structural colorectal screening\nexamination using CT Colonography. Includes exam performance, patient\nacceptance, cost effectiveness, image display technology, software and\nCT technology.\n \n \n \n \n \n \n Thomas Lauenstein, MD\n \n \n \n \n \n \n - Medical Director, Evangelical Hospital, Düsseldorf,\nGermany\n \n \...

More updates from Voyageur Pharmaceuticals Ltd